BioLargo, Inc. (BLGO)
OTCMKTS · Delayed Price · Currency is USD
0.0969
+0.0094 (10.74%)
At close: Sep 8, 2026
BioLargo Employees
As of December 31, 2025, BioLargo had 46 total employees, including 44 full-time and 2 part-time employees. The number of employees increased by 2 or 4.55% compared to the previous year.
Employees
46
Change
2
Growth
4.55%
Revenue / Employee
$90,711
Profits / Employee
-$321,911
Market Cap
31.85M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 46 | 2 | 4.55% | 44 | 2 |
| Sep 30, 2025 | 42 | -2 | -4.55% | 42 | 0 |
| Jun 30, 2025 | 42 | - | - | 42 | 0 |
| Mar 31, 2025 | 44 | 11 | 33.33% | 44 | 0 |
| Dec 31, 2024 | 44 | 11 | 33.33% | 40 | 4 |
| Dec 31, 2023 | 33 | 0 | - | 31 | 2 |
| Mar 31, 2023 | 33 | 2 | 6.45% | 33 | 0 |
| Dec 31, 2022 | 33 | 6 | 22.22% | 32 | 1 |
| Sep 30, 2022 | 31 | 4 | 14.81% | 31 | 0 |
| Jun 30, 2022 | 31 | 4 | 14.81% | 31 | 0 |
| Mar 31, 2022 | 31 | 4 | 14.81% | 31 | 0 |
| Dec 31, 2021 | 27 | 0 | - | 27 | 0 |
| Sep 30, 2021 | 27 | 4 | 17.39% | 27 | 0 |
| Jun 30, 2021 | 27 | 4 | 17.39% | 27 | 0 |
| Mar 31, 2021 | 27 | 2 | 8.00% | 27 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Venator Materials | 2,700 |
| Greystone Logistics | 82 |
| Kraig Biocraft Laboratories | 44 |
| Rubber Leaf | 10 |
| Blue Biofuels | 7 |
| Nocopi Technologies | 7 |
BioLargo News
- 5 days ago - BioLargo subsidiary adds third distribution channel, accelerate ViaClyr rollout - TheFly
- 5 days ago - BioLargo's Subsidiary Clyra Medical Adds Third Distribution Channel Accelerating Commercial Rollout of ViaClyr Wound Irrigation Solution - Accesswire
- 7 days ago - BioLargo, Inc. to Present at the Inaugural Nasdaq / LD Micro Summit on September 9, 2026 - Accesswire
- 14 days ago - BioLargo to Participate in Gabelli Funds' 4th Annual PFAS Symposium in New York - Accesswire
- 15 days ago - Gabelli To Host 4th Annual PFAS Symposium - GlobeNewsWire
- 22 days ago - BioLargo Reports Second Quarter 2026 Results; Revenue Up 12% Sequentially, Gross Margin Expands to 54% - Accesswire
- 25 days ago - BioLargo Quarterly report: Q2 2026 - Filings
- 25 days ago - BioLargo Earnings release: Q2 2026 - Filings